168 results on '"Del Baldo, Giada"'
Search Results
2. Tumor-derived G-CSF induces an immunosuppressive microenvironment in an osteosarcoma model, reducing response to CAR.GD2 T-cells
3. Pediatric brain tumor patients display altered immune activation and reduced lymphopoiesis at the onset of disease
4. The coexistence of a BRCA2 germline and a DICER1 somatic variant in two first-degree cousins suggests their potential synergic effect
5. Humoral and cellular immune response after mRNA SARS-CoV-2 vaccine in children on treatment for cancer: A pilot observational study
6. Cancer risk and tumour spectrum in 172 patients with a germline SUFU pathogenic variation: a collaborative study of the SIOPE Host Genome Working Group.
7. PATZ1-Rearranged Tumors of the Central Nervous System: Characterization of a Pediatric Series of Seven Cases
8. Venetoclax plus cyclophosphamide and topotecan in heavily pre-treated relapsed metastatic neuroblastoma: a single center case series
9. Allogeneic, donor-derived, second-generation, CD19-directed CAR-T cells for the treatment of pediatric relapsed/refractory BCP-ALL
10. Increased Prevalence of Celiac Disease in School-age Children in Italy
11. Pediatric CNS tumors and 2021 WHO classification: what do oncologists need from pathologists?
12. Case report: A safeguard in the sea of variants of uncertain significance: a case study on child with high risk neuroblastoma and acute myeloid leukemia
13. Factors associated with quality of life in Italian children and adolescents with IBD
14. Machine Learning Analysis in Diffusion Kurtosis Imaging for Discriminating Pediatric Posterior Fossa Tumors: A Repeatability and Accuracy Pilot Study.
15. Targeted therapy for pediatric central nervous system tumors harboring mutagenic tropomyosin receptor kinases
16. PATZ1-rearranged tumors of the central nervous system: characterization of a pediatric series of seven cases
17. Unraveling the impact of upfront chemotherapy and proton beam therapy on treatment outcome and follow-up in central nervous system germ cell tumors: a single center experience
18. Pediatric CNS tumors and 2021 WHO classification: what do oncologists need from pathologists?
19. Intrathoracic synovial sarcoma with BRAF V600E mutation
20. Allogeneic, donor-derived, second-generation, CD19-CAR-T cell for the treatment of pediatric relapsed/refractory BCP-ALL
21. Unlocking the power of precision medicine for pediatric low-grade gliomas: molecular characterization for targeted therapies with enhanced safety and efficacy
22. The peculiar challenge of bringing CAR-T cells into the brain: Perspectives in the clinical application to the treatment of pediatric central nervous system tumors
23. β-arrestin1-E2F1-ac axis regulates physiological apoptosis and cell cycle exit in cellular models of early postnatal cerebellum
24. Central Nervous System Metastasis in Neuroblastoma: From Three Decades Clinical Experience to New Considerations in the Immunotherapy Era
25. The Pitfall of Ganglioneuroblastoma-Nodular Diagnosis: Clinical and Imaging Considerations over a Rare Bifocal Sporadic Case
26. Full Sails against Cancer
27. Cerebellar mutism syndrome: From pathophysiology to rehabilitation
28. Multidisciplinary Management of Craniopharyngiomas in Children: A Single Center Experience
29. How Genetics and Genomics Advances Are Rewriting Pediatric Cancer Research and Clinical Care
30. Pediatric Diffuse Midline Gliomas: An Unfinished Puzzle
31. Cancer risk and tumour spectrum in 172 patients with a germlineSUFUpathogenic variation: a collaborative study of the SIOPE Host Genome Working Group
32. The Prognostic Role of the C-Reactive Protein and Serum Lactate Dehydrogenase in a Pediatric Series of Bone Ewing Sarcoma
33. Rethinking the Management of Optic Pathway Gliomas: A Single Center Experience
34. MEDB-75. Treatment-induced pulmonary toxicity in patients with medulloblastoma: a retrospective analysis on 2 Italian institutions’ cohorts
35. Evidence of pediatric sepsis caused by a drug resistant Lactococcus garvieae contaminated platelet concentrate
36. CAR-T Therapy for Pediatric High-Grade Gliomas: Peculiarities, Current Investigations and Future Strategies
37. The Fight Just Born—Neonatal Cancer: Rare Occurrence with a Favorable Outcome but Challenging Management
38. sj-docx-1-tam-10.1177_17588359221113693 – Supplemental material for Targeted therapy for pediatric diffuse intrinsic pontine glioma: a single-center experience
39. sj-docx-2-tam-10.1177_17588359221113693 – Supplemental material for Targeted therapy for pediatric diffuse intrinsic pontine glioma: a single-center experience
40. Frequency and characterization of cognitive impairments in patients diagnosed with paediatric central nervous system tumours: a systematic review.
41. Acute Hematological Toxicity during Cranio-Spinal Proton Therapy in Pediatric Brain Embryonal Tumors
42. Molecular Landscape in Infant High-Grade Gliomas: A Single Center Experience
43. Long‐term response to crizotinib in a 17‐year‐old boy with treatment‐naïve ALK‐positive non‐small‐cell lung cancer
44. Targeted therapy for pediatric diffuse intrinsic pontine glioma: a single-center experience
45. Cerebrospinal Fluid Levels of AFP and hCG: Validation of the Analytical Method and Application in the Diagnosis of Central Nervous System Germ Cell Tumors
46. Innovative and Promising Strategies to Enhance Effectiveness of Immunotherapy for CNS Tumors: Where Are We?
47. Molecular Characterization of Medulloblastoma in a Patient with Neurofibromatosis Type 1: Case Report and Literature Review
48. Rhabdoid Tumor Predisposition Syndrome: From Clinical Suspicion to General Management
49. Medulloblastoma Associated with Down Syndrome: From a Rare Event Leading to a Pathogenic Hypothesis
50. DICER1 Syndrome and Cancer Predisposition: From a Rare Pediatric Tumor to Lifetime Risk
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.